Actuate Therapeutics
Actuate Therapeutics is a small Molecules for Oncology founded in 2015.
1
Funding Rounds
$21.7m
Money raised
Overview
Actuate Therapeutics is a small Molecules for Oncology founded in 2015.
- Business model: B2B
Funding series
Funding Series Analysis
The company Actuate Therapeutics has raised a total of $21.7m in funding over 1 rounds.
Key Insights:
- Actuate Therapeutics Series B round, May 2019: $21.7m
Actuate Therapeutics Series B round, May 2019
$21.7m
Industries
Actuate Therapeutics is active in the following industries: